Marketing & Strategy
PRIME Awards 2020 call for entries – deadline extended

Marketing & Strategy: The PRIME Awards, the only awards program dedicated to recognising excellence within Australian healthcare communications, is now open for entries with key dates below.
Chair of Judges, Mr David Cousins, returns to oversee and facilitate judging, which this year broadens the review process with a mix of new and returning judges, all highly experienced in their field.
“I’m excited to follow up on the success of 2019 where we had our biggest year ever. To continue to ensure that the highest calibre of work is recognised, in 2020 we have evolved the judging process to a two-stage approach and welcomed new judges,” said Mr Cousins.
In light of the current COVID-19 restrictions, a decision will be made closer to the time regarding the format of the awards ceremony.
“Whilst the current situation is making the future seem uncertain, the PRIME Awards gives us time to reflect on our hard work and ultimately celebrate success – no matter what medium the awards ceremony may be held in” said Mr Cousins.
“Pausing to recognise innovation, collaboration and success in our industry is critical to increasing knowledge and skill as a whole.”

KEY INFORMATION
Entries Open Now and Close
Thursday 25th June
Finalists Announced
Early August
Awards Ceremony
Thursday 24th September
There are 18 categories for teams and individuals within the pharmaceutical and life sciences industry to shine. Full details of the categories and the entry kit can be found at www.primeawards.com.au
News & Trends - MedTech & Diagnostics

Policy paralysis: Private hospitals left to clean up the government’s mess on medical device reforms
Hospitals shouldn’t be forced to grovel to private health insurers to secure funding for essential, lifesaving medical devices. But thanks […]
MoreNews & Trends - Pharmaceuticals

Oncologists pioneer liquid biopsy-guided treatment in lung cancer
Lung cancer is Australia’s leading cause of cancer deaths. Local experts are set to lead a new frontier in personalised […]
MoreMedical and Science

The high cost of record low research funding
Australia has delivered some of the world’s most transformative health and medical breakthroughs – the cochlear implant, the HPV vaccine, […]
MoreNews & Trends - Pharmaceuticals

UCB secures dermatology indication with first dual IL-17A/F inhibitor
UCB’s IL-17A and IL-17F inhibitor has been added to the Australian Register of Therapeutic Goods (ARTG) for adults with moderate […]
More